Difficulty of Predicting Relapses in MOGAD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis and Related Disorders
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses
Mult Scler Relat Disord 2021 Nov 01;56(xx)103229, SE Epstein, S Levin, K Onomichi, C Langston, A Yeshokumar, M Fabian, IK Sand, S Klineova, F Lublin, K Dykstra, Z Xia, P De Jager, L Levine, R Farber, C Riley, WS VargasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.